Haploidentical transplants with a G-CSF/ATG-based protocol: Experience from China
Authors:
- 14 November 2022
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 62, 101035
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81930004, 82100227)
- National Key Research and Development Program of China (2019YFC0840606, 2021YFA1100904)
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001)
This publication has 68 references indexed in Scilit:
- Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignanciesBlood, 2013
- A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemiaBone Marrow Transplantation, 2012
- Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndromeBlood, 2011
- Granulocyte‐colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cellsEuropean Journal of Immunology, 2010
- Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donorsBone Marrow Transplantation, 2009
- The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCTBone Marrow Transplantation, 2008
- Mechanisms of action of antithymocyte globulin: T-cell depletion and beyondLeukemia, 2007
- Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportionsTransplant Immunology, 2007
- Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or LymphomaNew England Journal of Medicine, 1989
- MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIAThe Lancet, 1983